These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 2160156

  • 1. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive therapy of various autoimmune diseases of the nervous system].
    Neretin VIa, Odinokova VA, Kir'iakov VA, Sapfirova VA.
    Sov Med; 1990; (12):31-5. PubMed ID: 2097756
    [No Abstract] [Full Text] [Related]

  • 3. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 4. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
    Ravnborg M, Bendtzen K, Christensen O, Jensen PE, Hesse D, Tovey MG, Sørensen PS.
    Mult Scler; 2009 Mar; 15(3):323-8. PubMed ID: 19028832
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985 Mar; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 6. Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis.
    Mertin J, Knight SC, Rudge P, Thompson EJ, Healy MJ.
    Lancet; 1980 Nov 01; 2(8201):949-51. PubMed ID: 6107592
    [Abstract] [Full Text] [Related]

  • 7. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
    Dachsel R, Köppel C.
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jul 01; 41(7):420-5. PubMed ID: 2772076
    [Abstract] [Full Text] [Related]

  • 8. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S, Hohlfeld R.
    Nervenarzt; 1992 Feb 01; 63(2):116-9. PubMed ID: 1314334
    [No Abstract] [Full Text] [Related]

  • 9. [Immunosuppressive therapy].
    Fink U.
    Med Klin; 1969 Jun 06; 64(23):1069-72. PubMed ID: 4185573
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of graft rejection.
    Lancet; 1971 May 01; 1(7705):901-2. PubMed ID: 4102038
    [No Abstract] [Full Text] [Related]

  • 11. New treatments for multiple sclerosis.
    Hallpike JF.
    Br J Hosp Med; 1980 Jan 01; 23(1):63-4, 66, 68. PubMed ID: 6153540
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J.
    Fortschr Med; 1980 Oct 02; 98(37):1431-6. PubMed ID: 6253370
    [Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive treatment in neurological disorders].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1973 Jun 30; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract] [Full Text] [Related]

  • 14. [Review of the therapy of multiple sclerosis].
    De Rosa A, Puccini A, De Martino V.
    Recenti Prog Med; 1982 Dec 30; 73(6):651-68. PubMed ID: 6308734
    [No Abstract] [Full Text] [Related]

  • 15. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 16. Increased stimulation threshold in a patient with autoimmune disease: successful management with oral prednisolone and azathioprine.
    Ferraro A, Masi AS, Mazza A, Brusin MC, Conte MR.
    Europace; 2009 Apr 24; 11(4):527-9. PubMed ID: 19196719
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of the nephrotic syndrome].
    Nieth H.
    Dtsch Med Wochenschr; 1968 Mar 08; 93(10):454-6. PubMed ID: 4295747
    [No Abstract] [Full Text] [Related]

  • 18. [Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
    Störh M.
    Nervenarzt; 2002 Dec 08; 73(12):1207; author reply 1207. PubMed ID: 12599336
    [No Abstract] [Full Text] [Related]

  • 19. Quadruple immunosuppressive therapy for liver transplantation.
    Kalayoglu M, Stratta RJ, Hoffmann RM, Sollinger HW, Belzer FO.
    Transplant Proc; 1988 Feb 08; 20(1 Suppl 1):524-9. PubMed ID: 3279646
    [No Abstract] [Full Text] [Related]

  • 20. [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
    Gérard JM, Hildebrand J, Mavroudakis N, Monseu G, Przedborski S, Seeldrayers P, Wautier J, Zegers de Beyl D.
    Rev Med Brux; 1988 Sep 08; 9(6):334-9. PubMed ID: 2845554
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.